CROI 2016

Erik Mogalian presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.comErik Mogalian presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Drug interactions

Sofosbuvir/velpatasvir can be administered with most antiretrovirals

Imam Waked presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.comImam Waked presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Genotype 4

Ravidasvir plus sofosbuvir demonstrates high cure rate for people with hepatitis C genotype 4

Jurgen Rockstroh presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.comJurgen Rockstroh presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

HIV/HCV co-infection

Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low

infohep news